Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/1864
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Hurley, James C. | en_US |
dc.date.accessioned | 2022-01-27T04:44:55Z | - |
dc.date.available | 2022-01-27T04:44:55Z | - |
dc.date.issued | 2021 | - |
dc.identifier.govdoc | 01848 | en_US |
dc.identifier.uri | http://hdl.handle.net/11054/1864 | - |
dc.description | Comment on Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure. Johnson SW, Brown SV, Priest DH. Clin Infect Dis. 2020 Aug 22;71(5):1133-1139. doi: 10.1093/cid/ciz966. PMID: 31560051 Clinical Trial. | en_US |
dc.description.provenance | Submitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-01-12T00:22:05Z No. of bitstreams: 0 | en |
dc.description.provenance | Approved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-01-27T04:44:55Z (GMT) No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2022-01-27T04:44:55Z (GMT). No. of bitstreams: 0 Previous issue date: 2021 | en |
dc.title | Oral Vancomycin Prophylaxis for Clostridioides difficile Infection: Cause or Effect? | en_US |
dc.type | Journal Article | en_US |
dc.type.specified | Letter | en_US |
dc.bibliographicCitation.title | Clinical Infectious Diseases | en_US |
dc.bibliographicCitation.volume | 73 | en_US |
dc.bibliographicCitation.issue | 9 | en_US |
dc.bibliographicCitation.stpage | e2850 | en_US |
dc.bibliographicCitation.endpage | e2851 | en_US |
dc.subject.healththesaurus | ORAL VANCOMYCIN | en_US |
dc.subject.healththesaurus | CLOSTRIDIOIDES DIFFICILE | en_US |
dc.identifier.doi | https://doi.org/10.1093/cid/ciaa1424 | en_US |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.